f.demir
TL2 Regular · Izmir, TR
Interested in documentation quality as a proxy for process quality. A tidy COA is not proof, but a sloppy one is a signal.
Joined 3 July 2025 · last posted 6d · groups: translators
85 posts, newest first. Showing up to 150.
-
Seven-day rolling means and why weekly readings mislead Replied, post #84 · Outcomes › Progress reports · 22 Jul 2026 · 19 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #16 · Compounds › Oral incretins · 22 Jul 2026 · 0 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
A structured critique template this community uses — a second dataset Replied, post #39 · Evidence › Study critique · 15 Jul 2026 · 0 likes I read post #37 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
How to ask a question when you cannot say why you are asking it Replied, post #34 · Start Here › How to Ask · 8 Jul 2026 · 5 likes post #33 is right about the mechanism and I think understates the practical bit. Context that matters: compound, how long in, current dose, relevant history. Context…
-
Packaging that arrived damaged: documenting it properly Replied, post #36 · Sourcing › Logistics · 4 Jul 2026 · 3 likes Coming back to post #34, because the follow-up matters more than the original answer. Tracking stops updating: tracking last updated days ago usually means the package…
-
Insurance and replacement policies, compared Replied, post #60 · Sourcing › Logistics · 3 Jul 2026 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Pages past their review date, listed — does this still hold? Replied, post #22 · Meta › Wiki maintenance · 23 Jun 2026 · 21 likes Scope creep: if a page is attempting too much, suggesting it split into multiple pages can improve clarity.
-
Does dual agonism explain the effect size, or is it dose? Replied, post #38 · Compounds › Tirzepatide · 15 Jun 2026 · 3 likes Worth separating two things that post #34 runs together. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to…
-
Revisiting: The best-written scientific paper you have read Replied, post #29 · Lounge › Off topic · 13 Jun 2026 · 15 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #87 · Sourcing › Logistics · 31 May 2026 · 0 likes Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #24 · Outcomes › Body composition · 22 May 2026 · 5 likes Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Transporting a vial for a weekend away — a second dataset Replied, post #57 · Practice › Storage & stability · 19 May 2026 · 28 likes Picking up post #54: that is the part I would want checked first. Temperature excursions: if a vial sat at room temperature for a time, the question is whether the…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #47 · Compounds › Semaglutide · 1 May 2026 · 0 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Research-use-only status: what it means legally and practically Replied, post #33 · Compounds › Other compounds · 26 Apr 2026 · 30 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #5 · Outcomes › Body composition · 23 Apr 2026 · 10 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure.
-
Spike-and-recover accuracy for a peptide assay Replied, post #33 · Analytics › Method validation · 8 Apr 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A plateau that disappeared when I changed how I measured Replied, post #28 · Outcomes › Progress reports · 31 Mar 2026 · 6 likes On post #24 — agreed on the reasoning, with one qualification. Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #40 · Lounge › Introductions · 11 Mar 2026 · 0 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #7 · Evidence › Preprints · 7 Mar 2026 · 10 likes Picking up post #4: that is the part I would want checked first. Discussing preprints in this community: bring them in for early discussion, label them clearly as…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #14 · Compounds › Repair & healing peptides · 25 Feb 2026 · 0 likes Picking up post #11: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #108 · Analytics › Mass spectrometry · 15 Feb 2026 · 0 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #28 · Research Methods › N-of-1 designs · 4 Feb 2026 · 10 likes Worth separating two things that post #24 runs together. When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether…
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #7 · Compounds › Repair & healing peptides · 3 Feb 2026 · 0 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #104 · Clinical › Special populations · 26 Jan 2026 · 0 likes I read post #102 twice before replying, because I had assumed the opposite. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #2 · Practice › Dosing & titration · 24 Jan 2026 · 5 likes the opening post is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather…
-
Waist circumference technique and its repeatability Replied, post #39 · Outcomes › Progress reports · 16 Jan 2026 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #22 · Compounds › Oral incretins · 10 Jan 2026 · 0 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
Aggregates and why a purity assay may miss them entirely Replied, post #60 · Analytics › Impurities & related substances · 9 Jan 2026 · 0 likes On post #56 — agreed on the reasoning, with one qualification. Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #27 · Sourcing › Red flags · 26 Dec 2025 · 24 likes Worth separating two things that post #23 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #56 · Sourcing › Regulatory · 29 Nov 2025 · 3 likes Picking up post #53: that is the part I would want checked first. Primary documents matter: regulatory positions are published in official documents. Reading the…
-
Robustness: the parameters worth deliberately varying Replied, post #25 · Analytics › Method validation · 27 Nov 2025 · 6 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #62 · Analytics › Home & field testing · 25 Nov 2025 · 11 likes Worth separating two things that post #58 runs together. Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected…
-
Thyroid function tests during substantial weight change Replied, post #114 · Clinical › Bloodwork · 29 Oct 2025 · 3 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #105 · Start Here › Welcome · 22 Oct 2025 · 15 likes Picking up post #102: that is the part I would want checked first. The compound and evidence pages are updated regularly and they are worth reading when you are new.…
-
What pooling buys you and what it destroys Replied, post #46 · Evidence › Meta-analyses · 19 Oct 2025 · 15 likes post #45 is right about the mechanism and I think understates the practical bit. Fixed-effects versus random-effects models: fixed-effects assumes all studies are…
-
Absence of evidence and evidence of absence Replied, post #2 · Research Methods › Statistics · 11 Oct 2025 · 11 likes the opening post is right about the mechanism and I think understates the practical bit. Power and sample size: a study might be too small to detect a real effect (low…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #99 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 19 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
-
Specification in the result column: why that is a meaningful error Replied, post #51 · Analytics › COA interpretation · 29 Sep 2025 · 9 likes Coming back to post #49, because the follow-up matters more than the original answer. Endotoxin testing is separate: a certificate of purity says nothing about…
-
Documentation that materially improves an appeal's chances Replied, post #9 · Access › Insurance & coverage · 24 Sep 2025 · 10 likes Coming back to post #7, because the follow-up matters more than the original answer. Prior authorisation: pre-approval requirements and how to satisfy them. Most…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #38 · Analytics › COA interpretation · 19 Sep 2025 · 11 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #44 · Practice › Storage & stability · 19 Sep 2025 · 1 like post #43 is right about the mechanism and I think understates the practical bit. Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure…
-
Which panel is worth repeating and which is worth ignoring Replied, post #105 · Clinical › Bloodwork · 7 Sep 2025 · 11 likes Picking up post #102: that is the part I would want checked first. Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #19 · Analytics › Method validation · 28 Aug 2025 · 2 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #17 · Practice › Side effects · 26 Aug 2025 · 0 likes post #16 answers the question as asked. The question underneath it is different. Constipation: common, manageable, and frequently under-reported because it is not…
-
What this community means by "a source", in practical terms Replied, post #76 · Start Here › Welcome · 18 Aug 2025 · 16 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #6 · Data & Tools › Calculators · 17 Aug 2025 · 0 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
-
Asking about a compound your prescriber has not heard of Replied, post #125 · Clinical › Prescriber conversations · 13 Aug 2025 · 24 likes What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and records of any adverse effects you have experienced with other…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #48 · Practice › Dosing & titration · 9 Aug 2025 · 7 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #20 · Access › Pricing · 9 Aug 2025 · 21 likes List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #96 · Practice › Reconstitution · 6 Jul 2025 · 0 likes Worth separating two things that post #92 runs together. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #18 · Compounds › Secretagogues & GH axis · 24 Jun 2025 · 33 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
-
A ten-fold dose error caught before injection Replied, post #52 · Devices › Syringes & needles · 20 Jun 2025 · 0 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
A comparison of home results against a laboratory result on the same vial Replied, post #6 · Analytics › Home & field testing · 17 Jun 2025 · 1 like What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #7 · Pharmacology › Receptor biology · 15 Jun 2025 · 2 likes Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
-
Coming back to: Getting a referral rather than a refusal Replied, post #46 · Clinical › Prescriber conversations · 8 Jun 2025 · 11 likes Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after injection, severity 2 to 3 out of 4, stable over weeks".…
-
A well-designed study with a badly written abstract Replied, post #116 · Evidence › Study critique · 30 May 2025 · 24 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #20 · Compounds › Cagrilintide & amylin analogues · 26 May 2025 · 4 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #88 · Outcomes › Body composition · 24 May 2025 · 0 likes DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1 kg for lean mass. Two scans six months apart on the same…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #63 · Outcomes › Body composition · 19 May 2025 · 0 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
Publishing an inconvenient result: a case study Replied, post #21 · Sourcing › Independent verification · 17 May 2025 · 6 likes post #20 answers the question as asked. The question underneath it is different. Medutest: combined purity and identity reporting. Appears throughout vendor…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #83 · Access › Pricing · 30 Apr 2025 · 10 likes On post #79 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #2 · Clinical › Special populations · 26 Apr 2025 · 11 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
Hello from a laboratory that does not do peptides Replied, post #7 · Lounge › Introductions · 22 Apr 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Carryover and the ghost peak from last week's standard Replied, post #71 · Analytics › HPLC & UHPLC · 10 Apr 2025 · 26 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
Retatrutide dose escalation in the published trials Replied, post #87 · Compounds › Retatrutide · 4 Apr 2025 · 19 likes This follows post #84 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Carryover and the ghost peak from last week's standard Replied, post #2 · Analytics › HPLC & UHPLC · 31 Mar 2025 · 24 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #131 · Analytics › COA interpretation · 27 Mar 2025 · 14 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
When to suspect the method rather than the sample Replied, post #92 · Analytics › Method validation · 5 Mar 2025 · 0 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #13 · Practice › Reconstitution · 7 Feb 2025 · 5 likes On post #9 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #59 · Compounds › Secretagogues & GH axis · 30 Jan 2025 · 10 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
-
Protein density versus volume when you cannot eat much Replied, post #37 · Nutrition & Training › Protein & intake · 29 Jan 2025 · 14 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
Coming back to: Cost per delivered dose, which is the number that matters Replied, post #10 · Access › Pricing · 3 Jan 2025 · 6 likes I read post #8 twice before replying, because I had assumed the opposite. Biosimilars and future generics: as patents expire, biosimilar and generic versions might…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #11 · Compounds › Oral incretins · 1 Jan 2025 · 0 likes post #10 answers the question as asked. The question underneath it is different. Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #81 · Access › Insurance & coverage · 22 Dec 2024 · 1 like Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #27 · Compounds › Semaglutide · 20 Dec 2024 · 1 like Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #55 · Nutrition & Training › Protein & intake · 13 Dec 2024 · 13 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 11 Nov 2024 · 9 likes I read post #19 twice before replying, because I had assumed the opposite. What is genuinely unknown about long-term amylin agonism: real-world response rates, whether…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #45 · Clinical › Prescriber conversations · 9 Nov 2024 · 25 likes Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing, and any questions written out. Written questions get better…
-
Time to steady state after a dose increase Replied, post #150 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 0 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #106 · Analytics › COA interpretation · 4 Nov 2024 · 8 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Time to steady state after a dose increase Replied, post #64 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 0 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #5 · Practice › Interactions · 21 Oct 2024 · 10 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #9 · Clinical › Comorbidities · 9 Oct 2024 · 15 likes post #8 is right about the mechanism and I think understates the practical bit. Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #21 · Sourcing › Independent verification · 28 Aug 2024 · 5 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Promotion criteria, and the one that stops most nominations Replied, post #41 · Documentation › Doc review · 18 Aug 2024 · 0 likes Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you think the information exists but is scattered, suggest…